CDC's Healthcare Blog: How the landmark REDUCE MRSA trial came to be
Centers for Disease Control and Prevention (CDC) sent this bulletin at 05/31/2013 09:00 AM EDTToday, on CDC's Safe Healthcare Blog, CDC's Dr. John Jernigan provides insight into how a collaboration between public health, academia, and a health system took a novel idea from a hypothesis to 74,000 patients. Carried out by a multidisciplinary team from the University of California Irvine; Harvard Pilgrim Health Care Institute; Rush University; Stroger Hospital of Cook County; Washington University in St. Louis; Hospital Corporation of America and the CDC. The trial was federally funded by and conducted through research programs at the Agency for Healthcare Research and Quality (AHRQ) and the CDC’s Prevention Epicenters program.
Dr. John Jernigan is director of CDC’s Office of Prevention Research and Evaluation and head of CDC’s Prevention Epicenters Program.
Read the story behind the research at http://blogs.cdc.gov/safehealthcare/?p=2995.
Read the entire study in NEJM: http://www.nejm.org/doi/full/10.1056/NEJMoa1207290
Dr. John Jernigan is director of CDC’s Office of Prevention Research and Evaluation and head of CDC’s Prevention Epicenters Program.
Read the story behind the research at http://blogs.cdc.gov/safehealthcare/?p=2995.
Read the entire study in NEJM: http://www.nejm.org/doi/full/10.1056/NEJMoa1207290
.png)
No hay comentarios:
Publicar un comentario